About Robert Johnson
Robert Johnson is CEO, Kesmalea Therapeutics and director at Eikonoklastes Therapeutics.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Johnson in the role, so the role may have started earlier or lasted longer.
Eikonoklastes Therapeutics, Inc.
CEO, Kesmalea Therapeutics and director
2025 – 2026 · Cincinnati, OH
Develops gene therapies for people with ALS and other neurodegenerative diseases.
Key Colleagues at Startups
The people Robert Johnson works with at each company, as listed on that company's latest Form D.
Eikonoklastes Therapeutics, Inc. · Form D/A, Oct 6, 2026
Bruce Halpryn
Chairman and Chief Executive Officer
SL
Samuel Lee
President and Chief Business Officer, director
KM
Kenneth Morand
Partner, CincyTech and director
TF
Thomas Finn
Director
JN
Joseph Nolan
CEO, Jaguar Gene Therapy and director